Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Sangamo Therapeutics (SGMO)

Sangamo Therapeutics (SGMO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 172,980
  • Shares Outstanding, K 207,510
  • Annual Sales, $ 176,230 K
  • Annual Income, $ -257,830 K
  • 60-Month Beta 1.23
  • Price/Sales 0.99
  • Price/Cash Flow 23.04
  • Price/Book 7.43
Trade SGMO with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.12
  • Most Recent Earnings $-0.17 on 08/06/24
  • Next Earnings Date 11/06/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 167.30% ( +8.68%)
  • Historical Volatility 103.80%
  • IV Percentile 25%
  • IV Rank 10.18%
  • IV High 1,058.08% on 11/14/23
  • IV Low 66.32% on 05/08/24
  • Put/Call Vol Ratio 1.06
  • Today's Volume 192
  • Volume Avg (30-Day) 1,279
  • Put/Call OI Ratio 0.58
  • Today's Open Interest 53,454
  • Open Int (30-Day) 46,867

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate -0.07
  • Number of Estimates 3
  • High Estimate 0.02
  • Low Estimate -0.14
  • Prior Year -0.34
  • Growth Rate Est. (year over year) +79.41%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.7000 +19.59%
on 09/09/24
0.9598 -12.78%
on 08/22/24
-0.0429 (-4.87%)
since 08/16/24
3-Month
0.3040 +175.36%
on 07/05/24
1.2500 -33.03%
on 08/06/24
+0.4159 (+98.74%)
since 06/18/24
52-Week
0.2911 +187.56%
on 11/13/23
1.4800 -43.44%
on 02/16/24
-0.0304 (-3.50%)
since 09/18/23

Most Recent Stories

More News
3 Penny Stocks With 66% to 245% Upside Potential

Investing in these penny stocks could unlock extraordinary gains, with expected returns of up to 245%. Here are three analyst-recommended stocks from in-demand industries, all with significant upside potential....

AAPL : 220.69 (+1.80%)
AMZN : 186.43 (-0.24%)
LUNR : 7.47 (+38.33%)
SGMO : 0.8371 (+0.42%)
SVM : 3.97 (-2.93%)
$SPX : 5,618.26 (-0.29%)
PFE : 29.75 (-0.27%)
SIU24 : 30.341s (-0.91%)
GCZ24 : 2,584.0 (-0.56%)
Sangamo: Q2 Earnings Snapshot

Sangamo: Q2 Earnings Snapshot

SGMO : 0.8371 (+0.42%)
Sangamo: Q1 Earnings Snapshot

Sangamo: Q1 Earnings Snapshot

SGMO : 0.8371 (+0.42%)
Sangamo: Q4 Earnings Snapshot

Sangamo: Q4 Earnings Snapshot

SGMO : 0.8371 (+0.42%)
Sangamo: Q3 Earnings Snapshot

Sangamo: Q3 Earnings Snapshot

SGMO : 0.8371 (+0.42%)
Sangamo: Q2 Earnings Snapshot

Sangamo: Q2 Earnings Snapshot

SGMO : 0.8371 (+0.42%)
Sangamo Therapeutics to Present Pre-clinical Data From Its Genomic Engineering Platform at the 26th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)

Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today announced that the American Society of Gene & Cell Therapy (ASGCT) has accepted 14 Sangamo abstracts for presentation at the...

SGMO : 0.8371 (+0.42%)
Sangamo Therapeutics Announces Strategic Update and Reports Preliminary First Quarter 2023 Financial Results

Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicines company, today announced recent business highlights, including a strategic pipeline prioritization and restructuring, and reported certain...

SGMO : 0.8371 (+0.42%)
Sangamo Therapeutics Announces First Quarter 2023 Conference Call and Webcast

Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that the company is scheduled to release its first quarter 2023 financial results after the market closes on Wednesday,...

SGMO : 0.8371 (+0.42%)
Sangamo: Q4 Earnings Snapshot

Sangamo: Q4 Earnings Snapshot

SGMO : 0.8371 (+0.42%)

Business Summary

Sangamo Therapeutics, Inc. is a biotechnology company. It focuses on research and development of genomic therapies as well as develops medicines for patient with genetic diseases. The Company's product pipeline includes SB-525, SB-FIX, SB-318, SB-913, SB-728-T and SB-728-HSPC. Sangamo Therapeutics Inc.,...

See More

Key Turning Points

3rd Resistance Point 0.9252
2nd Resistance Point 0.9020
1st Resistance Point 0.8695
Last Price 0.8371
1st Support Level 0.8138
2nd Support Level 0.7906
3rd Support Level 0.7581

See More

52-Week High 1.4800
Fibonacci 61.8% 1.0258
Fibonacci 50% 0.8856
Last Price 0.8371
Fibonacci 38.2% 0.7453
52-Week Low 0.2911

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar